Novel dominant-negative FOXJ1 mutation in a family with heterotaxy plus mouse model

Lulu Li,Guocheng Shi,Xingyu Zhang,Teng Wang,Bo Wang,Yunqian Gao,Guoling You,Qihua Fu,Ying Xiang,Xiaoqing Zhang

DOI: https://doi.org/10.21037/tp-23-27

2023-08-29

Translational Pediatrics

Abstract:Keywords: FOXJ1 ; deletion mutation; dominant-negative effect; type 43 primary ciliary dyskinesia; congenital heart disease

pediatrics

What problem does this paper attempt to address?

Identification of FOXH1 Mutations in Patients with Sporadic Conotruncal Heart Defect

Wei,Bojian Li,Fen Li,Kun Sun,Xuechao Jiang,Rang Xu

DOI: https://doi.org/10.1111/cge.13710

2020-01-01

Clinical Genetics

Abstract:Conotruncal heart defects (CTD) are an important subtype of congenital heart disease that occur due to abnormality in the development of the cardiac outflow tract (OFT). FOXH1 is a transcription factor that participates in the morphogenesis of the right ventricle and OFT. In this study, we confirmed the expression of FOXH1 in mouse and human embryos during OFT development. We also scanned the coding exons and splicing regions of the FOXH1 gene in 605 patients with sporadic CTD and 300 unaffected controls, from which we identified seven heterozygous FOXH1 gene mutations. According to bioinformatics analysis results, they were predicted potentially deleterious at conserved amino acid sites. Western blot was used to show that all the variants decreased the expression of FOXH1 protein, while dual‐luciferase reporter assay showed that six of them, with an exception of p.P35R, had enhanced abilities to modulate the expression of MEF2C, which interacts with NKX2.5 and is involved in cardiac growth. The electrophoretic mobility shift assays result showed that two mutations altered DNA‐binding abilities of mutant FOXH1 proteins. Phenotype heterogeneity was found in patients with the same mutation. These results indicate that FOXH1 mutations lead to disease‐causing functional changes that contribute to the occurrence of CTD.
A Novel TBX1 Loss-of-Function Mutation Associated with Congenital Heart Disease.

Yun Pan,Zha-Gen Wang,Xing-Yuan Liu,Hong Zhao,Ning Zhou,Gui-Fen Zheng,Xing-Biao Qiu,Ruo-Gu Li,Fang Yuan,Hong-Yu Shi,Xu-Min Hou,Yi-Qing Yang

DOI: https://doi.org/10.1007/s00246-015-1173-x

2015-01-01

Pediatric Cardiology

Abstract:Congenital heart disease (CHD) is the most prevalent type of birth defect in humans and is the leading non-infectious cause of infant death worldwide. There is a growing body of evidence demonstrating that genetic defects play an important role in the pathogenesis of CHD. However, CHD is a genetically heterogeneous disease and the genetic basis underpinning CHD in an overwhelming majority of patients remains unclear. In this study, the coding exons and splice junction sites of the TBX1 gene, which encodes a T-box homeodomain transcription factor essential for proper cardiovascular morphogenesis, were sequenced in 230 unrelated children with CHD. The available family members of the index patient carrying an identified mutation and 200 unrelated ethnically matched healthy individuals used as controls were subsequently genotyped for TBX1. The functional effect of the TBX1 mutation was predicted by online program MutationTaster and characterized by using a dual-luciferase reporter assay system. As a result, a novel heterozygous TBX1 mutation, p.Q277X, was identified in an index patient with double outlet right ventricle (DORV) and ventricular septal defect (VSD). Genetic analysis of the proband's available relatives showed that the mutation co-segregated with CHD transmitted in an autosomal dominant pattern with complete penetrance. The nonsense mutation, which was absent in 400 control chromosomes, altered the amino acid that was completely conserved evolutionarily across species and was predicted to be disease-causing by MutationTaster. Biochemical analysis revealed that Q277X-mutant TBX1 lost transcriptional activating function when compared with its wild-type counterpart. This study firstly associates TBX1 loss-of-function mutation with enhanced susceptibility to DORV and VSD in humans, which provides novel insight into the molecular mechanism underlying CHD and suggests potential implications for the development of new preventive and therapeutic strategies for CHD.
Variants in FOXC1 and FOXC2 Identified in Patients with Conotruncal Heart Defects

Wei,Bojian Li,Fen Li,Kun Sun,Xuechao Jiang,Rang Xu

DOI: https://doi.org/10.1016/j.ygeno.2024.110840

IF: 4.31

2024-01-01

Genomics

Abstract:Conotruncal heart defects (CTD), subtypes of congenital heart disease, result from abnormal cardiac outflow tract development (OFT). FOXC1 and FOXC2 are closely related members of the forkhead transcription factor family and play essential roles in the development of OFT. We confirmed their expression pattern in mouse and human embryos, identifying four variants in FOXC1 and three in FOXC2 by screening these two genes in 605 patients with sporadic CTD. Western blot demonstrated expression levels, while Dual-luciferase reporter assay revealed affected transcriptional abilities for TBX1 enhancer in two FOXC1 variants and three FOXC2 variants. This might result from the altered DNA-binding abilities of mutant proteins. These results indicate that functionally impaired FOXC1 and FOXC2 variants may contribute to the occurrence of CTD.
A Novel ZIC3 Gene Mutation Identified in Patients with Heterotaxy and Congenital Heart Disease.

Shuolin Li,Sida Liu,Weicheng Chen,Yuan,Ruoyi Gu,Yangliu Song,Jian Li,Yinyin Cao,Yixiang Lin,Jun Xu,Huijun Wang,Duan Ma,Xiaojing Ma,Wei Sheng,Guoying Huang

DOI: https://doi.org/10.1038/s41598-018-30204-3

IF: 4.6

2018-01-01

Scientific Reports

Abstract:Heterotaxy syndrome (HTX) is characterized by left-right (LR) asymmetry disturbances associated with severe heart malformations. However, the exact genetic cause of HTX pathogenesis remains unclear. The aim of this study was to investigate the pathogenic mechanism underlying heterotaxy syndrome. Targeted next-generation sequencing (NGS) was performed for twenty-two candidate genes correlated with LR axis development in sixty-six HTX patients from unrelated families. Variants were filtered from databases and predicted in silico using prediction programs. A total of twenty-one potential disease-causing variants were identified in seven genes. Next, we used Sanger sequencing to confirm the identified variants in the family pedigree and found a novel hemizygous mutation (c. 890G > T, p. C297F) in the ZIC3 gene in a male patient that was inherited from his mother, who was a carrier. The results of functional indicated that this ZIC3 mutation decreases transcriptional activity, affects the affinity of the GLI-binding site and results in aberrant cellular localization in transfected cells. Moreover, morpholino-knockdown experiments in zebrafish demonstrated that zic3 mutant mRNA failed to rescue the abnormal phenotype, suggesting a role for the novel ZIC3 mutation in heterotaxy syndrome.
Lethal lung hypoplasia and vascular defects in mice with conditional Foxf1 overexpression

Avinash V. Dharmadhikari,Jenny J. Sun,Krzysztof Gogolewski,Brandi L. Carofino,Vladimir Ustiyan,Misty Hill,Tadeusz Majewski,Przemyslaw Szafranski,Monica J. Justice,Russell S. Ray,Mary E. Dickinson,Vladimir V. Kalinichenko,Anna Gambin,Paweł Stankiewicz

DOI: https://doi.org/10.1242/bio.019208

2016-11-15

Biology Open

Abstract:ABSTRACT FOXF1 heterozygous point mutations and genomic deletions have been reported in newborns with the neonatally lethal lung developmental disorder, alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV). However, no gain-of-function mutations in FOXF1 have been identified yet in any human disease conditions. To study the effects of FOXF1 overexpression in lung development, we generated a Foxf1 overexpression mouse model by knocking-in a Cre-inducible Foxf1 allele into the ROSA26 (R26) locus. The mice were phenotyped using micro-computed tomography (micro-CT), head-out plethysmography, ChIP-seq and transcriptome analyses, immunohistochemistry, and lung histopathology. Thirty-five percent of heterozygous R26-Lox-Stop-Lox (LSL)-Foxf1 embryonic day (E)15.5 embryos exhibit subcutaneous edema, hemorrhages and die perinatally when bred to Tie2-cre mice, which targets Foxf1 overexpression to endothelial and hematopoietic cells. Histopathological and micro-CT evaluations revealed that R26Foxf1; Tie2-cre embryos have immature lungs with a diminished vascular network. Neonates exhibited respiratory deficits verified by detailed plethysmography studies. ChIP-seq and transcriptome analyses in E18.5 lungs identified Sox11, Ghr, Ednrb, and Slit2 as potential downstream targets of FOXF1. Our study shows that overexpression of the highly dosage-sensitive Foxf1 impairs lung development and causes vascular abnormalities. This has important clinical implications when considering potential gene therapy approaches to treat disorders of FOXF1 abnormal dosage, such as ACDMPV.

biology
A Novel Forkhead Box L2 Missense Mutation, C.1068g>c, in a Chinese Family with Blepharophimosis/Ptosis/ Epicanthus Inversus Syndrome.

Shaoyun Wang,Shengfang Ge,Ai Zhuang

DOI: https://doi.org/10.1097/scs.0000000000008042

2021-01-01

Journal of Craniofacial Surgery

Abstract:The aim of the study was to report a novel forkhead box L2 (FOXL2) missense mutation in a Chinese blepharophimosis/ ptosis/epicanthus inversus syndrome family. Three generations of the Chinese family with blepharophimosis/ptosis/epicanthus inversus syndrome were enrolled in this study. Blood samples from patients of this family were collected and then analyzed by whole-exome sequencing. Confocal microscopy was performed to detect the subcellular location of FOXL2. Transactivation studies were performed and verified with real time polymerase chain reaction. A novel mutation (c.1068G>C) located in the downstream of deoxyribonucleic acid-binding forkhead domain was identified. Confocal photos showed the novel mutation did not disturb FOXL2 function, and the mutant protein could still transactivate steroidogenic acute regulatory protein, a key regulator of primary ovarian failure (POF). Our study revealed a novel missense mutation (c.1068G>C) and expanded the spectrum of FOXL2 gene mutations.
A dominant-negative SOX18 mutant disrupts multiple regulatory layers essential to transcription factor activity

Alex J McCann,Jieqiong Lou,Mehdi Moustaqil,Matthew S Graus,Ailisa Blum,Frank Fontaine,Hui Liu,Winnie Luu,Paulina Rudolffi-Soto,Peter Koopman,Emma Sierecki,Yann Gambin,Frédéric A Meunier,Zhe Liu,Elizabeth Hinde,Mathias Francois,Frédéric A Meunier

DOI: https://doi.org/10.1093/nar/gkab820

IF: 14.9

2021-09-27

Nucleic Acids Research

Abstract:Abstract Few genetically dominant mutations involved in human disease have been fully explained at the molecular level. In cases where the mutant gene encodes a transcription factor, the dominant-negative mode of action of the mutant protein is particularly poorly understood. Here, we studied the genome-wide mechanism underlying a dominant-negative form of the SOX18 transcription factor (SOX18RaOp) responsible for both the classical mouse mutant Ragged Opossum and the human genetic disorder Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome. Combining three single-molecule imaging assays in living cells together with genomics and proteomics analysis, we found that SOX18RaOp disrupts the system through an accumulation of molecular interferences which impair several functional properties of the wild-type SOX18 protein, including its target gene selection process. The dominant-negative effect is further amplified by poisoning the interactome of its wild-type counterpart, which perturbs regulatory nodes such as SOX7 and MEF2C. Our findings explain in unprecedented detail the multi-layered process that underpins the molecular aetiology of dominant-negative transcription factor function.

biochemistry & molecular biology
Novel heterozygous missense variants in the TOE1 gene linked to pontocerebellar hypoplasia type 7

Aijun Yang,Xiaoli Kong,Qin Wang,Runqing Miao,Haixiang Ma,Anzhuo Chu,Zhengtong Wang,Jiaqing Lu,Bo Liu,Bingcheng Mu,Runhan Guo,Jiayi Li,Xiaoxiao Gongye,Huabao Xiong,Tao Zhong

DOI: https://doi.org/10.1016/j.gendis.2024.101290

IF: 7.376

2024-05-06

Genes & Diseases

Abstract:Graphical abstract Download : Download high-res image (221KB) Download : Download full-size image

genetics & heredity,biochemistry & molecular biology
A Novel Missense Mutation Of Gata4 In A Chinese Family With Congenital Heart Disease

Xiaoqing Zhang,Jian Wang,Bo Wang,Sun Chen,Qihua Fu,Kun Sun

DOI: https://doi.org/10.1371/journal.pone.0158904

IF: 3.7

2016-01-01

PLoS ONE

Abstract:BackgroundCongenital heart disease (CHD) is the most prevalent type of birth defect in human, with high morbidity in infant. Several genes essential for heart development have been identified. GATA4 is a pivotal transcription factor that can regulate the cardiac development. Many GATA4 mutations have been identified in patients with different types of CHD.AimsIn this study, the NKX2-5, HAND1 and GATA4 coding regions were sequenced in a family spanning three generations in which seven patients had CHD. Disease-causing potential variation in this family was evaluated by bioinformatics programs and the transcriptional activity of mutant protein was analyzed by the dual luciferase reporter assay.ResultsA novel GATA4 mutation, c.C931T (p.R311W), was identified and co-segregated with the affected patients in this family. The bioinformatics programs predicted this heterozygous mutation to be deleterious and the cross-species alignment of GATA4 sequences showed that the mutation occurred within a highly conserved amino acid. Even though it resided in the nuclear localization signal domain, the mutant protein didn't alter its intracellular distribution. Nevertheless, further luciferase reporter assay demonstrated that the p.R311W mutation reduced the ability of GATA4 to activate its downstream target gene.ConclusionsOur study identified a novel mutation in GATA4 that likely contributed to the CHD in this family. This finding expanded the spectrum of GATA4 mutations and underscored the pathogenic correlation between GATA4 mutations and CHD.
HAND1 Loss-of-Function Mutation Causes Tetralogy of Fallot.

Juan Wang,Xiao-Qing Hu,Yu-Han Guo,Jian-Yun Gu,Jia-Hong Xu,Yan-Jie Li,Ning Li,Xiao-Xiao Yang,Yi-Qing Yang

DOI: https://doi.org/10.1007/s00246-016-1547-8

2016-01-01

Pediatric Cardiology

Abstract:As the most prevalent form of birth defect in humans worldwide, congenital heart disease (CHD) is responsible for substantial morbidity and is still the leading cause of birth defect-related demises. Increasing evidence demonstrates that genetic defects play an important role in the pathogenesis of CHD, and mutations in multiple genes, especially in those coding for cardiac core transcription factors, have been causally linked to various CHDs. Nevertheless, CHD is a genetically heterogeneous disease and the genetic determinants underpinning CHD in an overwhelming majority of patients remain elusive. In the current study, genomic DNA was extracted from venous blood samples of 165 unrelated patients with CHD, and the coding exons and splicing junction sites of the HAND1 gene, which encodes a basic helix-loop-helix transcription factor essential for cardiovascular development, were sequenced. As a result, a novel heterozygous mutation, p.R118C, was identified in a patient with tetralogy of Fallot (TOF). The missense mutation, which was absent in 600 referential chromosomes, altered the amino acid that was completely conserved evolutionarily. Biological assays with a dual-luciferase reporter assay system revealed that the R118C-mutant HAND1 protein had significantly reduced transcriptional activity when compared with its wild-type counterpart. Furthermore, the mutation significantly decreased the synergistic activation of a downstream target gene between HAND1 and GATA4, another cardiac core transcription factor associated with TOF. To our knowledge, this is the first report on the association of a HAND1 loss-of-function mutation with enhanced susceptibility to TOF in humans. The findings provide novel insight into the molecular etiology underlying TOF, suggesting potential implications for the improved prophylactic and therapeutic strategies for TOF.
Rare copy number variants analysis identifies novel candidate genes in heterotaxy syndrome patients with congenital heart defects

Chunjie Liu,Ruixue Cao,Yuejuan Xu,Tingting Li,Fen Li,Sun Chen,Rang Xu,Kun Sun

DOI: https://doi.org/10.1186/s13073-018-0549-y

IF: 15.266

2018-01-01

Genome Medicine

Abstract:Background Heterotaxy (Htx) syndrome comprises a class of congenital disorders resulting from malformations in left-right body patterning. Approximately 90% of patients with heterotaxy have serious congenital heart diseases; as a result, the survival rate and outcomes of Htx patients are not satisfactory. However, the underlying etiology and mechanisms in the majority of Htx cases remain unknown. The aim of this study was to investigate the function of rare copy number variants (CNVs) in the pathogenesis of Htx. Methods We collected 63 sporadic Htx patients with congenital heart defects and identified rare CNVs using an Affymetrix CytoScan HD microarray and real-time polymerase chain reaction. Potential candidate genes associated with the rare CNVs were selected by referring to previous literature related to left-right development. The expression patterns and function of candidate genes were further analyzed by whole mount in situ hybridization, morpholino knockdown, clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9)-mediated mutation, and over-expressing methods with zebrafish models. Results Nineteen rare CNVs were identified for the first time in patients with Htx. These CNVs include 5 heterozygous genic deletions, 4 internal genic duplications, and 10 complete duplications of at least one gene. Further analyses of the 19 rare CNVs identified six novel potential candidate genes ( NUMB , PACRG , TCTN2 , DANH10 , RNF115 , and TTC40 ) linked to left-right patterning. These candidate genes exhibited early expression patterns in zebrafish embryos. Functional testing revealed that downregulation and over-expression of five candidate genes ( numb , pacrg , tctn2 , dnah10 , and rnf115 ) in zebrafish resulted in disruption of cardiac looping and abnormal expression of lefty2 or pitx2 , molecular markers of left-right patterning. Conclusions Our findings show that Htx with congenital heart defects in some sporadic patients may be attributed to rare CNVs. Furthermore, DNAH10 and RNF115 are Htx candidate genes involved in left-right patterning which have not previously been reported in either humans or animals. Our results also advance understanding of the genetic components of Htx.
Novel association of LBX1 mutation with tetralogy of Fallot and hypertrophic cardiomyopathy: implications for cardiac development

Peiwen Cheng,Guozhen Wang,Yingzi Song,Yong An

DOI: https://doi.org/10.1038/s41598-024-77187-y

IF: 4.6

2024-10-31

Scientific Reports

Abstract:Background: Tetralogy of Fallot (TOF) and hypertrophic cardiomyopathy (HCM) are common types of congenital heart disease with unique pathophysiologic features. Mutations in LBX1, a key regulator of muscle precursor cell migration, may disrupt these critical developmental processes, resulting in severe developmental abnormalities. Case presentation: This case reports on a 4-year-old girl diagnosed with both TOF and HCM. Genetic analysis revealed iUPI-F (uniparental disomy) on the entire chromosome 10, with a c.808G > A (p. Glu270Lys) pure mutation in the LBX1. Conclusion: This patient exhibited both TOF and HCM with mutations in the LBX1 gene, suggesting a potentially novel genetic link. This case study emphasizes the need for further studies on the function of the LBX1 gene in cardiac development and its potential impact on TOF and HCM.

multidisciplinary sciences
Characterization of Human FOXN1 Mutations Uncovers both Loss- and Gain-of-Function Outcomes

Nicolai S van Oers,Angela Moses,Pratibha Bhalla,Christian Wysocki,Christine Seroogy,M. Louise Markert,M. Teresa de la Morena

DOI: https://doi.org/10.4049/jimmunol.208.supp.159.10

2022-05-01

The Journal of Immunology

Abstract:Abstract Thymus hypoplasia is reported for individuals with autosomal recessive, compound heterozygous and single allelic FOXN1 mutations. FOXN1 is the master transcriptional regulator of thymus epithelial cell development. Autosomal recessive mutations in FOXN1 lead to a Nude/SCID phenotype due to the ensuing T cell lymphopenia and impaired hair follicle extrusion. Targeted exome and whole genome sequencing for patients with low TRECs (measure of T cell output) has increased the number of diverse FOXN1 mutations to over 40. The consequence of these FOXN1 mutations on patients is varied and somewhat complicated by some individuals having only a transient delay in T cell development that corrects over time. We compared the functions of the FOXN1 mutants with luciferase reporter assays and nuclear localization experiments. For selected FOXN1 mutations, mice were developed to genocopy these to assess impacts on thymopoiesis. We identify partial and complete loss-of-function mutations along with gain-of-function and dominant negatives. Comparative analyses of murine thymopoiesis reveal some compound het Foxn1 mutations cause a transient thymus hypoplasia while others cause a permanent small thymus. Taken together, our findings establish FOXN1 genotype-phenotype relationships and suggest rapid functional screening approaches can be used to define the impact of different mutations of clinical relevance. Supported by grants from NIH (R01AI114523, R21AI144140) and the Jeffrey Modell Foundation (MdlM, CAW)

immunology
SOX7 loss-of-function variation as a cause of familial congenital heart disease

Ri-Tai Huang,Yu-Han Guo,Chen-Xi Yang,Jia-Ning Gu,Xing-Biao Qiu,Hong-Yu Shi,Ying-Jia Xu,Song Xue,Yi-Qing Yang

2022-01-01

American journal of translational research

Abstract:Introduction: As the most frequent type of birth defect in humans, congenital heart disease (CHD) leads to a large amount of morbidity and mortality as well as a tremendous socioeconomic burden. Accumulating studies have convincingly substantiated the pivotal roles of genetic defects in the occurrence of familial CHD, and deleterious variations in a great number of genes have been reported to cause various types of CHD. However, owing to pronounced genetic heterogeneity, the hereditary components underpinning CHD remain obscure in most cases. This investigation aimed to identify novel genetic determinants underlying CHD. Methods and results: A four-generation pedigree with high incidence of autosomal-dominant CHD was enrolled from the Chinese Han race population. Using whole-exome sequencing and Sanger sequencing assays of the family members available, a novel SOX7 variation in heterozygous status, NM_031439.4: c.310C>T; p.(GIn104*), was discovered to be in co-segregation with the CHD phenotype in the whole family. The truncating variant was absent in 500 unrelated healthy subjects utilized as control individuals. Functional measurements by dual-luciferase reporter analysis revealed that GIn104*-mutant SOX7 failed to transactivate its two important target genes, GATA4 and BMP2, which are both responsible for CHD. In addition, the nonsense variation invalidated the cooperative transactivation between SOX7 and NKX2.5, which is another recognized CHD-causative gene. Conclusion: The present study demonstrates for the first time that genetically defective SOX7 predisposes to CHD, which sheds light on the novel molecular mechanism underpinning CHD, and implies significance for precise prevention and personalized treatment in a subset of CHD patients.
Novel HOXD 13 frameshift mutation causes synpolydactyly and clinodactyly

Feng Ni,Gang Han,Ruiji Guo,Yu An,Bin Wang,Qingfeng Li

2018-01-01

Abstract:HOXD13 is a member of homeobox transcription factor genes essential for the vertebrate body plan. Mutations of this gene have been associated with different types of human limb deformities, including synpolydactyly, clinodactyly, and brachydactyly, but the gene-phenotype relationships are not fully understood. This study reports a novel heterozygous frameshift mutation of HOXD13 (c.610delC, p. P204fs61x) in a Chinese family with synpolydactyly and clinodactyly. This mutation was detected in the proband by whole-exome sequencing and confirmed by Sanger sequencing. This mutation co-segragated among family members with the phenotype. Furthermore, this study systemically reviewed previous studies and updated the gene-phenotype relationship for human HOXD13 mutations.
TBX20 Loss-of-function Mutation Responsible for Familial Tetralogy of Fallot or Sporadic Persistent Truncus Arteriosus.

Ri-Tai Huang,Juan Wang,Song Xue,Xing-Biao Qiu,Hong-Yu Shi,Ruo-Gu Li,Xin-Kai Qu,Xiao-Xiao Yang,Hua Liu,Ning Li,Yan-Jie Li,Ying-Jia Xu,Yi-Qing Yang

DOI: https://doi.org/10.7150/ijms.17834

2017-01-01

International Journal of Medical Sciences

Abstract:Congenital heart disease (CHD), the most common form of developmental abnormality in humans, remains a leading cause of morbidity and mortality in neonates. Genetic defects have been recognized as the predominant causes of CHD. Nevertheless, CHD is of substantial genetic heterogeneity and the genetic defects underlying CHD in most cases remain unclear. In the current study, the coding regions and splicing junction sites of the TBX20 gene, which encodes a T-box transcription factor key to cardiovascular morphogenesis, were sequenced in 175 unrelated patients with CHD, and a novel heterozygous TBX20 mutation, p.K274X, was identified in an index patient with tetralogy of Fallot (TOF). Genetic analysis of the proband's available family members showed that his father, elder brother and son had also TOF. In addition, his father and elder brother had also atrial septal defect, and his niece had persistent truncus arteriosus and ventricular septal defect. Analysis of the pedigree revealed that the mutation co-segregated with CHD transmitted in an autosomal dominant fashion, with complete penetrance. The nonsense mutation, which was absent in the 800 control chromosomes, was predicted to produce a truncated protein with only the amino terminus and partial T-box domain left. Functional analyses by using a dual-luciferase reporter assay system showed that the mutant TBX20 lost the ability to transactivate the target gene ANF. Furthermore, the mutation reduced the synergistic activation between TBX20 and NKX2.5 as well as GATA4, two other transcriptional factors previously associated with various CHD, encompassing TOF. This study firstly links TBX20 loss-of-function mutation to familial TOF or sporadic persistent truncus arteriosus, providing novel insight into the molecular pathogenesis of CHD.
A Novel HAND2 Loss-of-function Mutation Responsible for Tetralogy of Fallot.

Cai-Xia Lu,Hai-Rong Gong,Xing-Yuan Liu,Juan Wang,Cui-Mei Zhao,Ri-Tai Huang,Song Xue,Yi-Qing Yang

DOI: https://doi.org/10.3892/ijmm.2015.2436

IF: 5.314

2015-01-01

International Journal of Molecular Medicine

Abstract:Congenital heart disease (CHD), the most common type of developmental abnormality, is associated with substantial morbidity and mortality in humans worldwide. The basic helix-loop-helix transcription factor, heart and neural crest derivatives expressed 2 (HAND2), has been demonstrated to be crucial for normal cardiovascular development in animal models. However, whether a genetically defective HAND2 contributes to congenital heart disease (CHD) in humans remains to be explored. In this study, the entire coding region and splicing boundaries of the HAND2 gene were sequenced in a cohort of 145 unrelated patients with CHD. A total of 200 unrelated, ethnically-matched healthy individuals used as controls were also genotyped for HAND2. The functional effect of the mutant HAND2 was characterized in contrast to its wild-type counterpart by using a dual-luciferase reporter assay system. As a result, a novel heterozygous HAND2 mutation, p.L47P, was identified in a patient with tetralogy of Fallot (TOF). The misense mutation, which altered the amino acid conserved evolutionarily among species, was absent in 400 control chromosomes. Functional analyses unveiled that the mutant HAND2 had a significantly decreased transcriptional activity. Furthermore, the mutation markedly reduced the synergistic activation between HAND2 and GATA4 or NKX2.5, other two cardiac key transcription factors involved in the pathogenesis of CHD. To the best of our knowledge, this study is the first to report the association of a HAND2 loss-of-function mutation with an increased vulnerability to TOF in humans, which provides novel insight into the molecular mechanism underpinning CHD, suggesting potential implications for the genetic counseling of families with CHD.
A novel TSC1 frameshift mutation c.1550_1551del causes tuberous sclerosis complex by aberrant splicing and nonsense-mediated mRNA degradation (NMD) simultaneously in a Chinese family

Cong Qiu,Chengyan Li,Xiaoyun Tong,Luoyang Dai,Wenda Liu,Yulie Xie,Qimei Zhang,Guohua Yang,Tao Li

DOI: https://doi.org/10.1002/mgg3.1410

Abstract:Background: Tuberous sclerosis complex (TSC), belongs to autosomal dominant genetic disorder, which affects multiple organ systems in the body, including the skin, brain, lungs, kidneys, liver, and eyes. Mutations in TSC1 or TSC2 was proved to be associated with these conditions. Methods: Gene-panel Sequence of NGS was used to detect the mutation in a Chinese family. The research further investigates whether aberrant splicing and nonsense-mediated mRNA degradation (NMD) could serve as a mechanism cause by TSC1 mutation. MINI-Gene assay apply by pcMINI-TSC1wt/mut plasmids delivered in HeLa and 293T cell lines. Recombinant plasmids expressing wild-type and mutant-type EGFP-TSC1 were constructed and transiently transfected into human embryonic kidney cells 293T by lipofectamine. Real-time PCR and Western Blot were performed to analyze the expression of mRNAs and proteins of EGFP-TSC1 and NMD factor UPF1. Results: The gene test verified a novel heterozygous TSC1 frameshift mutation (TSC1 c.1550_1551del) in the proband and her mother. From MINI-Gene assay, the agarose gel showed that both the mutant and wild-type mRNA possess two main bands, indicating two splicing modes, named band A and B, respectively. The mutation c.1550_1551del has not produced new splicing site, but there is a selective splicing in varying degree significantly after mutation. On the contrary, function validation assay showed that cells transfected with the mutant TSC1 plasmids expressed significantly lower TSC1 in mRNAs and proteins levels, compared with the wild-type TSC1 plasmid transfection. A translation inhibitor cycloheximide and small interfering RNA of UPF1 (siRNA-UPF1) increased mRNA or protein expression of TSC1 significantly in cells transfected with the mutant plasmids. Conclusion: Our study demonstrated that the novel TSC1 frameshift mutation (TSC1 c.1550_1551del) trigger aberrant splicing and NMD simultaneously, causing decrease of hamartin, then, leading to tuberous sclerosis complex formation.
A Novel Small Deletion of LMX1B in a Large Chinese Family with Nail-Patella Syndrome

Xiaoyi Yan,Jie Lin,Yifan Wang,Junli Xuan,Ping Yu,Tingwei Guo,Fan Jin

DOI: https://doi.org/10.1186/s12881-019-0801-3

2019-01-01

BMC Medical Genetics

Abstract:BACKGROUND:Nail-patella syndrome (NPS) is an autosomal dominant developmental disorder most commonly characterized by dyplasia of nail or patella, the radial head or the humeral head hypoplasia, and, frequently ocular abnormalities and renal disease. It is caused by heterozygous loss-of-function mutations in the LMX1B gene, which encodes LIM homeodomain transcription factor and is essential for regulating the dorsal limb fate.METHODS:A five generation pedigree was recruited. Genomic DNA was extracted from the peripheral blood samples. Mutation detection was performed by Sanger sequencing the LMX1B gene. In silico functional annotation of the variant was performed using the in silico predictors SIFT, PolyPhen-2 and Mutation Taster.RESULTS:A novel heterozygous small deletion within exon 4 of LMX1B, c.712_714delTTC, was identified in a rare five-generation NPS pedigree. The mutation resulted in a deletion of the conserved amino acid phenylalanine at codon 238 (p.Phe238del), which located in the homeodomain of LMX1B may abolish DNA binding with the molecule. Conformational prediction showed that the variation could transform the helical structure comprising p.Phe234, p.Lys235, p.Ala236, and p.Ser237.CONCLUSION:We identified a novel NPS-causing LMX1B mutation and expanded the spectrum of mutations in the LMX1B gene. The c.712_714delTTC mutation may affect the quaternary structure of LMX1B, which is essential for the specification of dorsal limb fate at both zeugopodal and autopodal levels, leading to typical NPS.
A novel splicing mutation in 5'UTR of GJB1 causes X-linked Charcot-Marie-tooth disease

MeiYi Li,Minna Yin,Li Yang,Zhiheng Chen,Peng Du,Ling Sun,Juan Chen

DOI: https://doi.org/10.1002/mgg3.2108

Abstract:Background: Charcot-Marie-Tooth (CMT) disease is the most frequent hereditary motor sensory neurological disease. GJB1 gene is the second most frequent cause of CMT, accounting for approximately 10% of CMT cases worldwide. We identified a large Han family with X-linked CMT disease. Methods: In this study, the probands and his mother underwent electrophysiological examinations and other family members were assessed retrospectively. Whole-exome sequencing, Sanger sequencing, and SNP array linkage analysis were performed to find and confirm the variant. The functional effect of the identified variant was further investigated in HEK293 cells and MCF-7 cells by minigene splicing assay. Results: The affected individuals had some clinical symptoms including symmetric atrophy and progressive weakness of the distal muscles in their twenties. Electrophysiological examinations result in peripheral nerve injury of the upper and lower limbs. Whole-exome sequencing identified a novel hemizygous deletion mutation (NM_000166: c.-16-8_-14del) in the GJB1 gene. SNP array linkage analysis and co-segregation analysis confirmed this mutation. Minigene splicing assay verified that this mutation leads to the activation of cryptic splicing sites in exon 2 which results in the deletion of exon 2. Conclusion: Our study provides theoretical guidance for prenatal diagnosis and subsequent fertility of this family. This result expands the spectrum of mutations in GJB1 known to be associated with CMTX and contributes to the diagnosis of CMT and clinical genetic counseling.

Novel dominant-negative FOXJ1 mutation in a family with heterotaxy plus mouse model

Identification of FOXH1 Mutations in Patients with Sporadic Conotruncal Heart Defect

A Novel TBX1 Loss-of-Function Mutation Associated with Congenital Heart Disease.

Variants in FOXC1 and FOXC2 Identified in Patients with Conotruncal Heart Defects

A Novel ZIC3 Gene Mutation Identified in Patients with Heterotaxy and Congenital Heart Disease.

Lethal lung hypoplasia and vascular defects in mice with conditional Foxf1 overexpression

A Novel Forkhead Box L2 Missense Mutation, C.1068g>c, in a Chinese Family with Blepharophimosis/Ptosis/ Epicanthus Inversus Syndrome.

A dominant-negative SOX18 mutant disrupts multiple regulatory layers essential to transcription factor activity

Novel heterozygous missense variants in the TOE1 gene linked to pontocerebellar hypoplasia type 7

A Novel Missense Mutation Of Gata4 In A Chinese Family With Congenital Heart Disease

HAND1 Loss-of-Function Mutation Causes Tetralogy of Fallot.

Rare copy number variants analysis identifies novel candidate genes in heterotaxy syndrome patients with congenital heart defects

Novel association of LBX1 mutation with tetralogy of Fallot and hypertrophic cardiomyopathy: implications for cardiac development

Characterization of Human FOXN1 Mutations Uncovers both Loss- and Gain-of-Function Outcomes

SOX7 loss-of-function variation as a cause of familial congenital heart disease

Novel HOXD 13 frameshift mutation causes synpolydactyly and clinodactyly

TBX20 Loss-of-function Mutation Responsible for Familial Tetralogy of Fallot or Sporadic Persistent Truncus Arteriosus.

A Novel HAND2 Loss-of-function Mutation Responsible for Tetralogy of Fallot.

A novel TSC1 frameshift mutation c.1550_1551del causes tuberous sclerosis complex by aberrant splicing and nonsense-mediated mRNA degradation (NMD) simultaneously in a Chinese family

A Novel Small Deletion of LMX1B in a Large Chinese Family with Nail-Patella Syndrome

A novel splicing mutation in 5'UTR of GJB1 causes X-linked Charcot-Marie-tooth disease